LESLIE SIKES: Open Payments
NPI 1477887511 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,011 in 102 payments from 20 companies in 2025. Trend: 2023 $1,851 · 2024 $2,257 · 2025 $2,011
Food & beverage: $2,011
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $490 |
| GENZYME CORPORATION | 7 | $257 |
| Novartis Pharmaceuticals Corporation | 14 | $223 |
| Janssen Biotech, Inc. | 10 | $198 |
| LEO Pharma Inc. | 7 | $157 |
| Regeneron Healthcare Solutions, Inc. | 4 | $93 |
| Amgen Inc. | 5 | $86 |
| E.R. Squibb & Sons, L.L.C. | 4 | $80 |
| Lilly USA, LLC | 4 | $67 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $62 |
Products named: DUPIXENT, SKYRIZI, RINVOQ, TREMFYA, COSENTYX, ANZUPGO, OTEZLA, Sotyktu.
Industry payments across KS — which companies pay providers there.
